柴胡疏肝散加减治疗女性精神分裂症患者药源性高催乳素血症临床研究
DOI:
作者:
作者单位:

作者简介:

通讯作者:

中图分类号:

R749.3

基金项目:


Clinical Study on Modified Chaihu Shugan Powder for Drug- Induced Hyperprolac⁃ tinemia in Female Patients with Schizophrenia
Author:
Affiliation:

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
  • |
  • 文章评论
    摘要:

    目的:观察柴胡疏肝散加减治疗女性精神分裂症患者药源性高催乳素血症的临床疗效及安全性。方法:选取药源性高催乳素血症的女性精神分裂症患者116 例,按随机数字表法分为对照组和治疗组各58 例。2 组均给予口服氨磺必利,对照组采用甲磺酸溴隐亭片治疗,治疗组在对照组的基础上予以加减柴胡疏肝散治疗。2 组均治疗8 周。比较2 组临床疗效、治疗前后血清催乳素(PRL)、基础体温水平、自然杀伤(NK) 细胞活性、T 淋巴细胞亚群(CD3+、CD4+、CD8+) 水平变化情况,并对药物的安全性进行评价。结果:治疗组临床总有效率为89.66%,显著高于对照组的75.86%,差异有统计学意义(P<0.05)。治疗2、4、8 周,2 组血清PRL 水平均较治疗前下降(P<0.05),且在相同时间点治疗组血清PRL 水平均低于对照组(P<0.05)。治疗前,2 组基础体温情况比较,差异无统计学意义(P>0.05);治疗后,治疗组基础体温改善优于对照组(P<0.05)。治疗前,2 组NK 细胞活性、T 淋巴细胞亚群水平比较,差异无统计学意义(P>0.05)。治疗后,2 组NK 细胞活性、CD3+均较治疗前升高(P<0.05),2 组CD4+水平均较治疗前降低(P<0.05),且治疗组3 项指标改善较对照组更显著(P<0.05);2 组CD8+水平较治疗前升高(P<0.05),但组间比较差异无统计学意义(P>0.05)。治疗组不良反应发生率为13.78%,对照组为15.51%,2 组比较,差异无统计学意义(P>0.05)。结论:柴胡疏肝散加减治疗女性精神分裂症患者药源性高催乳素血症,能明显改善患者血清PRL 水平和基础体温,改善免疫功能,且不良反应相对较少。

    Abstract:

    Abstract:Objective:To observe the clinical effect and the safety of modified Chaihu Shugan powder for drug-induced hyperprolactinemia in female patients with schizophrenia. Methods:A total of 116 cases of female schizophrenic patients with drug-induced hyperprolactinemia were selected and divided into the control group and the treatment group according to the random number table method,with 58 cases in each group. Both groups were given oral administration of amisulpiride;the control group was treated with bromocriptine mesylate tablets, and the treatment group was additionally treated with modified Chaihu Shugan powder based on the treatment of the control group. Both groups were treated for eight weeks. The changes in levels of serum prolactin(PRL),basal body temperatures,natural killer(NK) cell activity and T lymphocyte subsets including CD3+,CD4+ and CD8+ before and after treatment and the clinical effects in the two groups were compared. The drug safety was evaluated. Results:The total clinical effective rate was 89.66% in the treatment group,significantly higher than that of 75.86% in the control group, the difference being significant(P<0.05). After treatment for two, four and eight weeks,the PRL levels in serum in the two groups were decreased when compared with those before treatment(P<0.05), and the PRL levels in serum in the treatment group at the same time points were lower than those in the control group(P< 0.05). Before treatment, there was no significant difference being found in the comparison of basal body temperatures between the two groups(P>0.05). After treatment,the improvement of basal body temperature in the treatment group was better than that in the control group(P<0.05). Before treatment, there was no significant difference being found in the comparison of NK cell activity and levels of T lymphocyte subsets between the two groups(P>0.05). After treatment,the NK cell activity and CD3+ levels in the two groups were increased when compared with those before treatment(P<0.05),and the CD4 + levels in the two groups were decreased(P<0.05),and the improvement of the above three indexes in the treatment group was more significant than that in the control group(P<0.05);the CD8+ levels in the two groups were increased when compared with those before treatment(P<0.05),but there was no significance in the difference(P>0.05). The incidence of adverse reactions was 13.78% in the treatment group and 15.51% in the control group,there being no significance in the difference(P>0.05). Conclusion: Modified Chaihu Shugan powder for drug- induced hyperprolactinemia in female patients with schizophrenia can effectively improve serum PRL levels,basal body temperatures and immune function,with relatively few adverse reactions.

    参考文献
    相似文献
    引证文献
引用本文

郑顺.柴胡疏肝散加减治疗女性精神分裂症患者药源性高催乳素血症临床研究[J].新中医,2022,54(12):51-55

复制
分享
文章指标
  • 点击次数:
  • 下载次数:
  • HTML阅读次数:
  • 引用次数:
历史
  • 收稿日期:
  • 最后修改日期:
  • 录用日期:
  • 在线发布日期: 2022-06-22
  • 出版日期: